Literature DB >> 8841692

Prevalence and detection of illicit drug disorders among hospitalized patients.

M D Stein1, J Wilkinson, N Berglas, P O'Sullivan.   

Abstract

The objective of this study was to determine the prevalence of a lifetime history of illicit drug dependence--abuse among hospitalized patients, and to determine the rate of identification of these patients by physicians. This cross-sectional study included patient interview and chart review in an acute-care teaching hospital. The participants were 235 randomly selected inpatients with medical, neurologic, or surgical diagnoses. The prevalence of life-time history of dependence--abuse of at least one class of illicit drug was 11.9%. Across all classes of drugs, hospitalized patients had higher prevalences than community estimates. Only 18% of patients had documentation of having been asked about illicit drug use compared to 49% having been asked about alcohol use. There was no significant difference in physicians' asking across clinical services: Medicine 21%, Neurology 15%, Surgery 14%. Smokers, unmarried persons, and patients without a regular physician were most likely to have been asked. Screening for drug abuse is not routinely performed and documented among hospitalized patients. Wider identification of persons at risk for drug use may allow for specific physician interventions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841692     DOI: 10.3109/00952999609001672

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  6 in total

1.  Screening patients for alcohol, tobacco, and other drug misuse: the role of brief interventions.

Authors:  C A Aristeiguieta
Journal:  West J Med       Date:  2000-01

2.  Managing acutely ill substance-abusing patients in an integrated day hospital outpatient program: medical therapies, complications, and overall treatment outcomes.

Authors:  Thomas P O'Toole; Alicia Conde-Martel; J Hunter Young; Jennifer Price; George Bigelow; Daniel E Ford
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

3.  Outpatient treatment entry and health care utilization after a combined medical/substance abuse intervention for hospitalized medical patients.

Authors:  Thomas P O'Toole; Eric C Strain; Gary Wand; Mary E McCaul; Matthew Barnhart
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

4.  Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.

Authors:  Jane M Liebschutz; Denise Crooks; Debra Herman; Bradley Anderson; Judith Tsui; Lidia Z Meshesha; Shernaz Dossabhoy; Michael Stein
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

5.  Estimating the prevalence of illicit opioid use in New York City using multiple data sources.

Authors:  Jennifer McNeely; Marc N Gourevitch; Denise Paone; Sharmila Shah; Shana Wright; Daliah Heller
Journal:  BMC Public Health       Date:  2012-06-18       Impact factor: 3.295

Review 6.  Diagnosing co-morbid drug use in patients with alcohol use disorders.

Authors:  Bachaar Arnaout; Ismene L Petrakis
Journal:  Alcohol Res Health       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.